Skip to main content
. Author manuscript; available in PMC: 2014 Sep 19.
Published in final edited form as: J Surg Res. 2013 Oct 2;187(1):128–133. doi: 10.1016/j.jss.2013.09.042

Figure 4.

Figure 4

In vitro, western blot data showing the expression of (A) autophagy makers LC3A and LC3B, Beclin-1, (B) phosphorylation of AMPK, and (C) mTOR in TG treated HepG2 cells. (D) Cytosolic ATP level alteration in HepG2 cell with TG challenge. Data are mean ± SEM. * p<0.05, TG treated group vs. vehicle treated group.